Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2025 Filed Mar 17, 2025 20:07 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Tax withholdingCommon Stock | 4,316 | $58.83 | $253,910.28 |
DisclosureSEC source: 0001127602-25-009658 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,896.635 Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 20:07 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionCommon Stock | 4,500 | $55.42 | $249,390.00 |
DisclosureSEC source: 0001127602-25-009658 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,212.635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 18:27 UTC |
Lalomia BrentVice President QA and RA
|
Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 75 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-009019 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75 Underlying: Common Stock · 75 shares Expires 2032-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 18:27 UTC |
Lalomia BrentVice President QA and RA
|
Tax withholdingCommon Stock | 26 | $62.74 | $1,631.24 |
DisclosureSEC source: 0001127602-25-009019 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,006.057 Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 18:27 UTC |
Lalomia BrentVice President QA and RA
|
Exercise / conversionCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-009019 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,032.057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:11 UTC |
Clifford Edward A.VP Global Manufacturing
|
GrantOptions To Purchase Common Stock · Derivative | 26,127 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008298 · form4.xml · derivative · entry 1 Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,127 Underlying: Common Stock · 26,127 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:10 UTC |
Foust Hollie KGeneral Counsel & Corp Sec
|
GrantOptions To Purchase Common Stock · Derivative | 30,738 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008297 · form4.xml · derivative · entry 1 Foust Hollie K · CIK 0002043157 · General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,738 Underlying: Common Stock · 30,738 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 20:45 UTC |
Ferrell John D.Executive Vice President - HR
|
GrantOptions To Purchase Common Stock · Derivative | 21,516 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008271 · form4.xml · derivative · entry 1 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,516 Underlying: Common Stock · 21,516 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 20:42 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
GrantOptions To Purchase Common Stock · Derivative | 9,300 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008270 · form4.xml · derivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 9,300 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 20:40 UTC |
Lalomia BrentVice President QA and RA
|
GrantOptions To Purchase Common Stock · Derivative | 26,895 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008269 · form4.xml · derivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,895 Underlying: Common Stock · 26,895 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 20:38 UTC |
Glaze RichardChief Information Officer
|
GrantOptions To Purchase Common Stock · Derivative | 11,750 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008268 · form4.xml · derivative · entry 1 Glaze Richard · CIK 0002025615 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,750 Underlying: Common Stock · 11,750 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 20:35 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
GrantOptions To Purchase Common Stock · Derivative | 26,127 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008266 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,127 Underlying: Common Stock · 26,127 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 20:36 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantOptions To Purchase Common Stock · Derivative | 61,475 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008267 · form4.xml · derivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,475 Underlying: Common Stock · 61,475 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 03, 2025 Filed May 15, 2025 13:59 UTC |
Epinette StephanVP GM International
|
GrantRSUs (Restricted Stock Units) · Derivative | 17,144 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014389 · form4.xml · derivative · entry 1 Epinette Stephan · CIK 0001507941 · VP GM International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,144 Underlying: Common Stock · 17,144 shares Expires 2035-03-03 F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in a four year period with zero (0) shares vesting in 2026; 8,572 shares vesting on 3/3/27; 6,429 shares vesting on 3/3/28 and 2,143 vesting on 3/3/29. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 14:33 UTC |
Kaye MarkDirector
|
GrantRSUs (Restricted Stock Units) · Derivative | 152 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006784 · form4.xml · derivative · entry 2 Kaye Mark · CIK 0001748691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152 Underlying: Common Stock · 152 shares Expires 2035-02-24 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 14:33 UTC |
Kaye MarkDirector
|
GrantOptions To Purchase Common Stock · Derivative | 1,846 | $0.00 Strike: $61.97 | $0.00 |
DisclosureSEC source: 0001127602-25-006784 · form4.xml · derivative · entry 1 Kaye Mark · CIK 0001748691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,846 Underlying: Common Stock · 1,846 shares Expires 2035-02-24 F1 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 20:01 UTC |
Glaze RichardChief Information Officer
|
SaleCommon Stock | 257 | $65.35 | $16,796.03 |
DisclosureSEC source: 0001127602-25-004596 · form4.xml · nonDerivative · entry 1 Glaze Richard · CIK 0002025615 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 22:48 UTC |
Moller Andrew JamesVP Corporate Controller
|
GrantOptions To Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $71.18 | $0.00 |
DisclosureSEC source: 0001127602-25-002512 · form4.xml · derivative · entry 1 Moller Andrew James · CIK 0002054340 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2035-01-27 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:19 UTC |
Beyer PatPresident & CEO
|
GrantOptions To Purchase Common Stock · Derivative | 86,355 | $0.00 Strike: $67.35 | $0.00 |
DisclosureSEC source: 0001127602-25-000752 · form4.xml · derivative · entry 1 Beyer Pat · CIK 0001627985 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,355 Underlying: Common Stock · 86,355 shares Expires 2035-01-02 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 31, 2024 Filed Apr 7, 2025 17:07 UTC |
Lalomia BrentExecutive VP RA, QA
|
Other401 (K) Plan | 22.993 | $68.44 | $1,573.64 |
DisclosureSEC source: 0001127602-25-011741 · form5.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Executive VP RA, QA 10b5-1 filing: No plan indicated Ownership: Indirect · 401 (K) Plan Disclosed balance after: 93.606 F1 · date: As of December 31, 2024. Read SEC document |
| November 20, 2024 Filed Nov 21, 2024 21:13 UTC |
Glaze RichardChief Information Officer
|
Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-027803 · form4.xml · derivative · entry 3 Glaze Richard · CIK 0002025615 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,125 Underlying: Common Stock · 375 shares Expires 2033-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| November 20, 2024 Filed Nov 21, 2024 21:13 UTC |
Glaze RichardChief Information Officer
|
Tax withholdingCommon Stock | 118 | $70.69 | $8,341.42 |
DisclosureSEC source: 0001127602-24-027803 · form4.xml · nonDerivative · entry 2 Glaze Richard · CIK 0002025615 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257 Read SEC document |
| November 20, 2024 Filed Nov 21, 2024 21:13 UTC |
Glaze RichardChief Information Officer
|
Exercise / conversionCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-027803 · form4.xml · nonDerivative · entry 1 Glaze Richard · CIK 0002025615 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 22:02 UTC |
Hartman Curt RDirector · President and CEO
|
Exercise / conversionSARs (Stock Appreciation Rights) · Derivative | 30,000 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-24-026855 · form4.xml · derivative · entry 4 Hartman Curt R · CIK 0001451535 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,300 Underlying: Common Stock · 30,000 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (20%) over a five year period. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 22:02 UTC |
Hartman Curt RDirector · President and CEO
|
Tax withholdingCommon Stock | 24,303 | $74.76 | $1,816,892.28 |
DisclosureSEC source: 0001127602-24-026855 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,996 Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 22:02 UTC |
Hartman Curt RDirector · President and CEO
|
Exercise / conversionCommon Stock | 30,000 | $51.30 | $1,539,000.00 |
DisclosureSEC source: 0001127602-24-026855 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 23:57 UTC |
Foust Hollie KGeneral Counsel & Corp Sec
|
GrantRSUs (Restricted Stock Units) · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-026616 · form4.xml · derivative · entry 1 Foust Hollie K · CIK 0002043157 · General Counsel & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company"). F2 · derivative.exercise_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 50% vesting after year 1 and 50% vesting after year 2. F2 · derivative.expiration_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 50% vesting after year 1 and 50% vesting after year 2. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 19:26 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantRSUs (Restricted Stock Units) · Derivative | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-026454 · form4.xml · derivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,727 Underlying: Common Stock · 22,727 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company"). F2 · derivative.exercise_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2. F2 · derivative.expiration_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 14:46 UTC |
Farkas CharlesDirector
|
Exercise / conversionSARs (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001127602-24-023639 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2024-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs vesting on June 1, 2015 and expiring on September 11, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 14:46 UTC |
Farkas CharlesDirector
|
Tax withholdingCommon Stock | 534 | $74.31 | $39,681.54 |
DisclosureSEC source: 0001127602-24-023639 · form4.xml · nonDerivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,346 Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 14:46 UTC |
Farkas CharlesDirector
|
Exercise / conversionCommon Stock | 1,000 | $39.64 | $39,640.00 |
DisclosureSEC source: 0001127602-24-023639 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 19:20 UTC |
Clifford Edward A.VP Global Manufacturing
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021576 · form4.xml · derivative · entry 3 Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 500 shares Expires 2033-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 19:20 UTC |
Clifford Edward A.VP Global Manufacturing
|
Tax withholdingCommon Stock | 122 | $65.34 | $7,971.48 |
DisclosureSEC source: 0001127602-24-021576 · form4.xml · nonDerivative · entry 2 Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378 Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 19:20 UTC |
Clifford Edward A.VP Global Manufacturing
|
Exercise / conversionCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021576 · form4.xml · nonDerivative · entry 1 Clifford Edward A. · CIK 0001988929 · VP Global Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 20:22 UTC |
Peters Stanley W IIIPresident AS and AET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-24-018832 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 20:22 UTC |
Peters Stanley W IIIPresident AS and AET
|
SaleCommon Stock | 4,000 | $71.82 | $287,280.00 |
DisclosureSEC source: 0001127602-24-018832 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 20:22 UTC |
Peters Stanley W IIIPresident AS and AET
|
Exercise / conversionCommon Stock | 4,000 | $41.93 | $167,720.00 |
DisclosureSEC source: 0001127602-24-018832 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:12 UTC |
Workman John LDirector
|
GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017851 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:12 UTC |
Workman John LDirector
|
GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017851 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:11 UTC |
Bronson David M.Director
|
GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017850 · form4.xml · derivative · entry 4 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:11 UTC |
Bronson David M.Director
|
GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017850 · form4.xml · derivative · entry 3 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:08 UTC |
Aronson Martha GoldbergDirector
|
GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017848 · form4.xml · derivative · entry 5 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:08 UTC |
Aronson Martha GoldbergDirector
|
GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017848 · form4.xml · derivative · entry 4 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:09 UTC |
Farkas CharlesDirector
|
GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017849 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:09 UTC |
Farkas CharlesDirector
|
GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017849 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:06 UTC |
Council LaVerne HDirector
|
GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017847 · form4.xml · derivative · entry 4 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:06 UTC |
Council LaVerne HDirector
|
GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017847 · form4.xml · derivative · entry 3 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:05 UTC |
Schwarzentraub Barbara JDirector
|
GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017846 · form4.xml · derivative · entry 5 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:05 UTC |
Schwarzentraub Barbara JDirector
|
GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017846 · form4.xml · derivative · entry 4 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 13:33 UTC |
Concannon BrianDirector
|
GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017863 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.